HomeInsightsStock Comparison

Advanced Enzyme Technologies Ltd vs Deep Health Ai India Ltd Stock Comparison

Advanced Enzyme Technologies Ltd vs Deep Health Ai India Ltd Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

  • The Latest Trading Price of Advanced Enzyme Technologies Ltd is ₹ 357.1 as of 05 May 15:30 . The P/E Ratio of Advanced Enzyme Technologies Ltd changed from 29.1 on March 2024 to 24.5 on March 2023 . This represents a CAGR of -3.38% over 5 yearsThe P/E Ratio of Deep Health AI India Ltd changed from 65.7 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years The Market Cap of Advanced Enzyme Technologies Ltd changed from ₹ 3885 crore on March 2024 to ₹ 2590 crore on March 2023 . This represents a CAGR of -7.79% over 5 yearsThe Market Cap of Deep Health AI India Ltd changed from ₹ 18.91 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Advanced Enzyme Technologies Ltd for the Dec '25 is ₹ 191.66 crore as compare to the Sep '25 revenue of ₹ 194.81 crore. This represent the decline of -1.62% The revenue of Deep Health AI India Ltd for the Dec '25 is ₹ 4.21 crore as compare to the Sep '25 revenue of ₹ 3.51 crore. This represent the growth of 19.94% The ebitda of Advanced Enzyme Technologies Ltd for the Dec '25 is ₹ 69.07 crore as compare to the Sep '25 ebitda of ₹ 70.34 crore. This represent the decline of -1.81% The ebitda of Deep Health AI India Ltd for the Dec '25 is ₹ 3.67 crore as compare to the Sep '25 ebitda of ₹ 3.39 crore. This represent the growth of 8.26% The net profit of Advanced Enzyme Technologies Ltd changed from ₹ 34.98 crore to ₹ 43.18 crore over 7 quarters. This represents a CAGR of 12.79% The net profit of Deep Health AI India Ltd changed from ₹ 0.29 crore to ₹ 3.04 crore over 7 quarters. This represents a CAGR of 282.94% The Dividend Payout of Advanced Enzyme Technologies Ltd changed from 14.16 % on March 2021 to 56.81 % on March 2025 . This represents a CAGR of 32.03% over 5 yearsThe Dividend Payout of Deep Health AI India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Advanced Enzyme Technologies Ltd

  • Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that transformed business globally in the manufacturing and sale of enzymes.
  • The Company was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra.
  • It thereafter converted the status into a Public Company and the name of the Company was changed to Advanced Biochemicals Limited on May 28, 1992 and further was changed to Advanced Enzyme Technologies Limited via fresh Certificate of Incorporation at RoC, Mumbai on August 19, 2005. In 2011, the company took over Cal-India Foods International, giving the company direct presence in USA. In 2012, the company took over Advanced Supplementary Technologies Corporation for consolidating its presence in USA. Advanced Enzyme Technologies Limited came out with its Initial Public Offer (IPO) of 4,594,875 Equity shares of Rs 10 each at an issue price of Rs 896 per Equity share ( Rs 810 per Equity share for eligible employees), consisting of fresh issue of 560,405 Equity shares and an Offer for Sale of 4,034,470 Equity shares by Selling Shareholders.

About Deep Health AI India Ltd

  • Deep Diamond India Limited was established in 1994, with the object to engaged in the manufacture and wholesale of gold set jewellery with diamonds.
  • The company also deals in loose diamonds, solitaires, and gold frames.
  • It offers Pendants, Nose pins, Rings, Bangles, Earrings, Pendant sets, Necklace sets, Bracelets, and others. From financial year 2022-23, the Company has also started business of providing consultancy service to Pharmaceutical Industry. During year 2023, Company diversified its business into pharmaceuticals business with professional management team at its Board.
  • Located in Mumbai, Deep Diamond India is a pharmaceutical company that focuses on developing and marketing innovative drugs and therapies to address unmet medical needs.
  • Their product portfolio includes prescription drugs, over-the-counter medicines, and medical devices.

FAQs for the comparison of Advanced Enzyme Technologies Ltd and Deep Health AI India Ltd

Which company has a larger market capitalization, Advanced Enzyme Technologies Ltd or Deep Diamond India Ltd?

Market cap of Advanced Enzyme Technologies Ltd is 3,959 Cr while Market cap of Deep Diamond India Ltd is 34 Cr

What are the key factors driving the stock performance of Advanced Enzyme Technologies Ltd and Deep Diamond India Ltd?

The stock performance of Advanced Enzyme Technologies Ltd and Deep Diamond India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Advanced Enzyme Technologies Ltd and Deep Diamond India Ltd?

As of May 5, 2026, the Advanced Enzyme Technologies Ltd stock price is INR ₹353.8. On the other hand, Deep Diamond India Ltd stock price is INR ₹2.39.

How do dividend payouts of Advanced Enzyme Technologies Ltd and Deep Diamond India Ltd compare?

To compare the dividend payouts of Advanced Enzyme Technologies Ltd and Deep Diamond India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions